Efficacy of Intravitreal Brolucizumab Switch in Pachychoroid Neovasculopathy
Abstract Introduction This study aimed to evaluate the anatomical and functional outcomes of switching to intravitreally administered brolucizumab (Beovu®, Novartis) in patients affected by pachychoroid neovasculopathy (PNV) who were considered as non-responders to previous anti-vascular endothelial...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Adis, Springer Healthcare
2025-07-01
|
| Colección: | Ophthalmology and Therapy |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/s40123-025-01208-w |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|